Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial. - Rodler, Eve; Sharma, Priyanka; Barlow, William E; Gralow, Julie R; Puhalla, Shannon L; Anders, Carey K; Goldstein, Lori; Tripathy, Debu; Brown-Glaberman, Ursa A; Huynh, Thu-Tam; Szyarto, Christopher S; Godwin, Andrew K; et al. (Lancet Oncology, 2023)